References
- Tally F P, Cuchural G J, Jacobus N V, et al. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother 1983; 23: 536–40
- Sutter V L, Citron D M, Edelstein M AC, Finegold S M. Wadsworth anaerobic bacteriology manual, 4th ed. Star Publishing Company, California 1985
- Brown J E, Del Bene V E, Collins C D. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother 1981; 19: 248–52
- Eley A, Greenwood D. Characterization of β-lactamases in clinical isolates of Bacteroides. J Antimicrob Chemother 1986; 18: 325–33
- Reading C, Cole M. Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother 1977; 11: 852–7
- Holdeman L V, Cato E P, Moore W EC. Anaerobe laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg 1977
- Goldstein E JC, Citron D M. Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother 1986; 29: 159–60
- Fox A R, Phillips I. The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom. J Antimicrob Chemother 1987; 20: 477–88
- Tally F P, Jacobus N V. Susceptibility of anaerobic bacteria to imipenem. J Antimicrob Chemother 1983; 12(Suppl D)47–51
- Neu H C, Labthavikul P. Comparative in vitro activity of N-formimidoyl thienamycin against Gram-positive and Gram-negative aerobic and anaerobic species and its β-lactamase stability. Antimicrob Agents Chemother 1982; 21: 180–7
- Dixson S, Andrew J H. The in vitro activity of the newer β-lactam antibiotics against 124 strains of Gram-negative bacilli. Pathology 1985; 17: 636–9
- Brown E M. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid. J Antimicrob Chemother 1984; 14: 367–72
- Appelbaum P C, Jacobs M R, Spangler S K, Yamabe S. Comparative activity of β-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with β-lactams against β-lactamase-producmg anaerobes. Antimicrob Agents Chemother 1986; 30: 789–91